PTAB Won't Review Japanese Co.'s Antibody Tech Patents
The U.S. Patent Trial and Appeal Board has declined to review three patents belonging to Japanese pharmaceutical company Kyowa Hakko Kirin, saying Aragen Bioscience and Transposagen Biopharmaceuticals failed to show that...To view the full article, register now.
Already a subscriber? Click here to view full article